Fifty-year-old migraine treatment being phased out

+Print Archive

Fifty-year-old migraine treatment being phased out

Jonathan
Chilton-Towle
headache
The migraine treatment Cafergot (AFT Pharmaceuticals) will no longer be approved for use in New Zealand from May next year. On 20 November, Medsaf